Efek Eicosapentaenoic Acid Terhadap CD8+dalam Darah Pasien Kanker Payudara Stadium III B yang Mendapat Kemoterapi Cyclophosphamide Adriamycin Fluorouracyl Siklus Pertama (The effect of eicosapentaenoic acid on COB + number of breast cancer stadium 1118 patients receiving first cycle CAP) | Perpustakaan Badan Kebijakan Pembangunan Kesehatan

Search by :

ALL Author Subject ISBN/ISSN Advanced Search

Last search:

Text

Efek Eicosapentaenoic Acid Terhadap CD8+dalam Darah Pasien Kanker Payudara Stadium III B yang Mendapat Kemoterapi Cyclophosphamide Adriamycin Fluorouracyl Siklus Pertama (The effect of eicosapentaenoic acid on COB + number of breast cancer stadium 1118 patients receiving first cycle CAP)

Rudiyuwono Raharjo - Personal Name; Darwito - Personal Name; Edi Dharmana - Personal Name;

Background: Eicosapenaenoic acid (EPA) has immune-modulating effects and may improve nutritional status in cancer especially in relation to its role in tumour cachexia. The aim ofthe study was to evaluate the efficacy of administration eicosapentaenoic acid for increasing the CD8+ of the stadium IIIB invasive ductus breast cancer patients underwent the first cycle chemotherapy with Cyclophosphamide Adriamycin Fluorouracyl.
Methods: The experimental study was conducted to women with stadium IIIB invasive ductus breast cancer who underwent chemotherapy with Cyclophosphamide Adriamycin Fluorouracyl (CAF) cycle I. The subjects were divided into 2 groups, the experimental group who got the EPA 225 g/day for 21 days and the control group without the EPA supplementation. The CD8+ cells numberwere measured before and after supplementation.
Results: Forty patients treated on the first cycle of CAF chemotherapy decided into 2 groups equaly. Twenty people on the experimental group and 20 on the control group. The number of CD8+ on the experimental group was significantly increased 1131,7 cells/µl (483-3506) compared the control group 631,8 cells/µl (227-1616) (p< 0,05). After 21 days, significant differences between CD8+ cells number were observed before and after supplementation on both group (p

Availability

Location name is not set Media Hospitallia, 1 (1) 2012 : 47-52

A0003311

Available

Detail Information

Series Title: -
Call Number: Media Hospitallia, 1 (1) 2012 : 47-52
Publisher: Semarang : Puslitbang Farmasi, Badan Litbang Kesehatan., 2012
Collation: 6p
Language
ISBN/ISSN: 2301-4369
Classification: -
Content Type: -
Media Type: -
Carrier Type: -
Edition: -
Subject(s): -
Specific Detail Info: -
Statement of Responsibility: -

Other version/related

No other version available

File Attachment

No Data

Comments

You must be logged in to post a comment